Key facts
- This page summarizes Mark E. Delaney's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2025, 16:34.
Mark E. Delaney - 04 Mar 2025 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP & Chief Commercial Officer
- Issuer ticker
- DGX
- Reported as of
- 04 Mar 2025
- Net transaction value
- +$607,048
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2025, 16:34:58 UTC
- Prior SEC filing
- 28 Feb 2025
- Next SEC filing
- 28 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Mark E. Delaney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark E. Delaney filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 05 Mar 2025.
Change
- Previous filing in this sequence was filed on 28 Feb 2025.
- Current net transaction value: +$607,048.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Award
- Transaction value
- $923,776
- Shares
- +5,317
- Change %
- +89%
- Price
- $173.74
- Shares after
- 11,300
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Tax liability
- Transaction value
- $316,728
- Shares
- -1,823
- Change %
- -16%
- Price
- $173.74
- Shares after
- 9,477
- Date
- 04 Mar 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
Footnote F2
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.